Long-term Safety and Efficacy of GBG Study Participants

计划入组 400 人 · 首次发布于 2023 年 2 月 22 日

Treatment of Peri-implantitis Lesions by Using Biomaterial

计划入组 71 人 · 首次发布于 2015 年 3 月 3 日

Impact of PAX Good Behavior Game on Elementary School Students in Estonia

计划入组 708 人 · 首次发布于 2016 年 8 月 12 日

GBD-219

GBD-216

GBV-1028

GBG Forschungs GmbH

Germany

EBG MedAustron GmbH

Austria

GMG ArcData LLC

United States

Greenwich LifeSciences Expands Phase III Breast Cancer Trial Globally, Adds New Sites and Expertise

Atezolizumab Fails to Improve Event-Free Survival in Triple-Negative Breast Cancer

Phase 3 DESTINY-Breast05 Trial Compares Trastuzumab Deruxtecan to T-DM1 in High-Risk HER2+ Early Breast Cancer